Measles virus fusion protein: Structure, function and inhibition

Viruses

Volumn 8, Issue 4, 2016, Pages

  Plattet, Philippe ^a   Alves, Lisa ^b   Herren, Michael ^a   Aguilar, Hector C ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cell entry; Fusion protein; Inhibitors and mechanisms of adaptation; Measles virus; Membrane fusion; Neuroinvasion; Structural changes

Indexed keywords

ANTI F INHIBITORY ANTIBODY; ANTI F PEPTIDIC INHIBITOR; ANTI F SMALL MOLECULE BLOCKER; CD150 ANTIGEN; CELL RECEPTOR; HN PROTEIN; HYBRID PROTEIN; NECTIN 2; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; ANTIVIRUS AGENT; PROTEIN BINDING; VIRUS FUSION INHIBITOR; VIRUS RECEPTOR;

CANINE DISTEMPER VIRUS; CRYOELECTRON MICROSCOPY; ENCEPHALITIS; ENDOPLASMIC RETICULUM; ENERGY TRANSFER; F H BINDING INTERFACE; H HEAD; H STALK; HUMAN; MEASLES VIRUS; MODEL; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; PROTEOMICS; REVIEW; SAFETY CATCH MODEL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ENVELOPE; ANTAGONISTS AND INHIBITORS; BINDING SITE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; HOST PATHOGEN INTERACTION; MEASLES; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; STRUCTURE ACTIVITY RELATION; VIROLOGY; VIRUS ENTRY;

ANTIVIRAL AGENTS; BINDING SITES; DRUG DISCOVERY; HOST-PATHOGEN INTERACTIONS; HUMANS; MEASLES; MEASLES VIRUS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; RECEPTORS, VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL FUSION PROTEIN INHIBITORS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

EID: 84964237314     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8040112     Document Type: Review

References (196)

1. Lamb, R.A., Parks, G.D. Paramyxoviridae: The viruses and their replication. In Fields’ Virology, 5th ed., Fileds, B., Knipe, D.M., Howley, P.M., Eds., Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1449-1496.
2. Simons, E., Ferrari, M., Fricks, J., Wannemuehler, K., Anand, A., Burton, A., Strebel, P. Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data. Lancet 2012, 379, 2173-2178. [CrossRef]
3. Plemper, R.K., Hammond, A.L. Synergizing vaccinations with therapeutics for measles eradication. Expert Opin. Drug Discov. 2014, 9, 201-214. [CrossRef] [PubMed]
4. Chua, K.B., Bellini, W.J., Rota, P.A., Harcourt, B.H., Tamin, A., Lam, S.K., Ksiazek, T.G., Rollin, P.E., Zaki, S.R., Shieh, W., et al. Nipah virus: A recently emergent deadly paramyxovirus. Science 2000, 288, 1432-1435. [CrossRef] [PubMed]
5. Westbury, H.A., Hooper, P.T., Selleck, P.W., Murray, P.K. Equine morbillivirus pneumonia: Susceptibility of laboratory animals to the virus. Aust. Vet. J. 1995, 72, 278-279. [CrossRef] [PubMed]
6. Williamson, M.M., Hooper, P.T., Selleck, P.W., Gleeson, L.J., Daniels, P.W., Westbury, H.A., Murray, P.K. Transmission studies of hendra virus (equine morbilli-virus) in fruit bats, horses and cats. Aust. Vet. J. 1998, 76, 813-818. [CrossRef] [PubMed]
7. Guillaume, V., Contamin, H., Loth, P., Grosjean, I., Courbot, M.C., Deubel, V., Buckland, R., Wild, T.F. Antibody prophylaxis and therapy against nipah virus infection in hamsters. J. Virol. 2006, 80, 1972-1978. [CrossRef] [PubMed]
8. Roelke-Parker, M.E., Munson, L., Packer, C., Kock, R., Cleaveland, S., Carpenter, M., O’Brien, S.J., Pospischil, A., Hofmann-Lehmann, R., Lutz, H., et al. A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 1996, 379, 441-445. [CrossRef] [PubMed]
9. Sakai, K., Nagata, N., Ami, Y., Seki, F., Suzaki, Y., Iwata-Yoshikawa, N., Suzuki, T., Fukushi, S., Mizutani, T., Yoshikawa, T., et al. Lethal canine distemper virus outbreak in cynomolgus monkeys in japan in 2008. J. Virol. 2013, 87, 1105-1114. [CrossRef] [PubMed]
10. Osterhaus, A.D., Vedder, E.J. Identification of virus causing recent seal deaths. Nature 1988, 335, 20. [CrossRef] [PubMed]
11. Hall, A.J. Morbilliviruses in marine mammals. Trends Microbiol. 1995, 3, 4-9. [CrossRef]
12. Kennedy, S. Morbillivirus infections in aquatic mammals. J. Comp. Pathol. 1998, 119, 201-225. [CrossRef]
13. Origgi, F.C., Plattet, P., Sattler, U., Robert, N., Casaubon, J., Mavrot, F., Pewsner, M.; Wu, N., Giovannini, S., Oevermann, A., et al. Emergence of canine distemper virus strains with modified molecular signature and enhanced neuronal t opism leading to high mortality in wild carnivores. Vet. Pathol. 2012, 49, 913-929. [CrossRef] [PubMed]
14. Normile, D. Animal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease. Science 2010, 330, 435. [CrossRef] [PubMed]
15. Albina, E., Kwiatek, O., Minet, C., Lancelot, R., Servan de Almeida, R., Libeau, G. Peste des petits ruminants, the next eradicated animal disease? Vet. Microbiol. 2013, 165, 38-44. [CrossRef] [PubMed]
16. Stone, B.M., Blyde, D.J., Saliki, J.T., Blas-Machado, U., Bingham, J., Hyatt, A.; Wang, J., Payne, J., Crameri, S. Fatal cetacean morbillivirus infection in an australian offshore bottlenose dolphin (Tursiops truncatus). Aust. Vet. J. 2011, 89, 452-457. [CrossRef] [PubMed]
17. Philip Earle, J.A., Melia, M.M., Doherty, N.V., Nielsen, O., Cosby, S.L. Phocine distemper virus in seals, east coast, United States, 2006. Emerg. Infect. Dis. 2011, 17, 215-220. [CrossRef] [PubMed]
18. Moss, W.J., Griffin, D.E. Global measles elimination. Nat. Rev. Microbiol. 2006, 4, 900-908. [CrossRef] [PubMed]
19. Butler, D. Measles by the numbers: A race to eradication. Nature 2015, 518, 148-149. [CrossRef] [PubMed]
20. Kupferschmidt, K. Public health. Europe’s embarrassing problem. Science 2012, 336, 406-407. [CrossRef] [PubMed]
21. Sammons, J.S. Responding to measles in the postelimination era. Ann. Intern. Med. 2014, 161, 841-842. [CrossRef] [PubMed]
22. Mina, M.J., Metcalf, C.J., de Swart, R.L., Osterhaus, A.D., Grenfell, B.T. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015, 348, 694-699. [CrossRef] [PubMed]
23. Krumm, S.A., Yan, D., Hovingh, E.S., Evers, T.J., Enkirch, T., Reddy, G.P., Sun, A., Saindane, M.T., Arrendale, R.F., Painter, G., et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci. Transl. Med. 2014, 6, 232-252. [CrossRef] [PubMed]
24. Mathieu, C., Huey, D., Jurgens, E., Welsch, J.C., DeVito, I., Talekar, A., Horvat, B., Niewiesk, S., Moscona, A., Porotto, M. Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J. Virol. 2015, 89, 1143-1155. [CrossRef] [PubMed]
25. Welsch, J.C., Talekar, A., Mathieu, C., Pessi, A., Moscona, A., Horvat, B., Porotto, M. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J. Virol. 2013, 87, 13785-13794. [CrossRef] [PubMed]
26. McLellan, J.S., Ray, W.C., Peeples, M.E. Structure and function of respiratory syncytial virus surface glycoproteins. Curr. Top. Microbiol. Immunol. 2013, 372, 83-104. [PubMed]
27. De Vries, R.D., Mesman, A.W., Geijtenbeek, T.B., Duprex, W.P., de Swart, R.L. The pathogenesis of measles. Curr. Opin. Virol. 2012, 2, 248-255. [CrossRef] [PubMed]
28. Ferreira, C.S., Frenzke, M., Leonard, V.H., Welstead, G.G., Richardson, C.D., Cattaneo, R. Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J. Virol. 2010, 84, 3033-3042. [CrossRef] [PubMed]
29. Avota, E., Koethe, S., Schneider-Schaulies, S. Membrane dynamics and interactions in measles virus dendritic cell infections. Cell. Microbiol. 2013, 15, 161-169. [CrossRef] [PubMed]
30. Koethe, S., Avota, E., Schneider-Schaulies, S. Measles virus transmission from dendritic cells to t cells: Formation of synapse-like interfaces concentrating viral and cellular components. J. Virol. 2012, 86, 9773-9781. [CrossRef] [PubMed]
31. Lemon, K., de Vries, R.D., Mesman, A.W., McQuaid, S., van, A.G., Yuksel, S., Ludlow, M., Rennick, L.J., Kuiken, T., Rima, B.K., et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 2011, 7, e1001263. [CrossRef] [PubMed]
32. Ludlow, M., McQuaid, S., Milner, D., de Swart, R.L., Duprex, W.P. Pathological consequences of systemic measles virus infection. J. Pathol. 2015, 235, 253-265. [CrossRef] [PubMed]
33. Buchanan, R., Bonthius, D.J. Measles virus and associated central nervous system sequelae. Semin. Pediatr. Neurol. 2012, 19, 107-114. [CrossRef] [PubMed]
34. Vandevelde, M., Zurbriggen, A. Demyelination in canine distemper virus infection: A review. Acta Neuropathol. 2005, 109, 56-68. [CrossRef] [PubMed]
35. Norrby, E., Kristensson, K. Measles virus in the brain. Brain Res. Bull. 1997, 44, 213-220. [CrossRef]
36. Bonaparte, M.I., Dimitrov, A.S., Bossart, K.N., Crameri, G., Mungall, B.A., Bishop, K.A., Choudhry, V., Dimitrov, D.S.; Wang, L.F., Eaton, B.T., et al. Ephrin-b2 ligand is a functional receptor for hendra virus and nipah virus. Proc. Natl. Acad. Sci. USA 2005, 102, 10652-10657. [CrossRef] [PubMed]
37. Negrete, O.A., Levroney, E.L., Aguilar, H.C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., Lee, B. Ephrinb2 is the entry receptor for nipah virus, an emergent deadly paramyxovirus. Nature 2005, 436, 401-405. [CrossRef] [PubMed]
38. Negrete, O.A., Wolf, M.C., Aguilar, H.C., Enterlein, S., Wang, W., Muhlberger, E., Su, S.V., Bertolotti-Ciarlet, A., Flick, R., Lee, B. Two key residues in ephrinb3 are critical for its use as an alternative receptor for nipah virus. PLoS Pathog. 2006, 2, e7. [CrossRef] [PubMed]
39. Palmer, A., Klein, R. Multiple roles of ephrins in mor phogenesis, neuronal networking, and brain function. Genes Dev. 2003, 17, 1429-1450. [CrossRef] [PubMed]
40. Tatsuo, H., Ono, N., Tanaka, K., Yanagi, Y. Slam (CDW150) is a cellular receptor for measles virus. Nature 2000, 406, 893-897. [PubMed]
41. Tatsuo, H., Ono, N., Yanagi, Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol. 2001, 75, 5842-5850. [CrossRef] [PubMed]
42. Noyce, R.S., Bondre, D.G., Ha, M.N., Lin, L.T., Sisson, G., Tsao, M.S., Richardson, C.D. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7, e1002240. [CrossRef] [PubMed]
43. Muhlebach, M.D., Mateo, M., Sinn, P.L., Prufer, S., Uhlig, K.M., Leonard, V.H., Navaratnarajah, C.K., Frenzke, M., Wong, X.X., Sawatsky, B., et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480, 530-533. [CrossRef] [PubMed]
44. Pratakpiriya, W., Seki, F., Otsuki, N., Sakai, K., Fukuhara, H., Katamoto, H., Hirai, T., Maenaka, K., Techangamsuwan, S., Lan, N.T., et al. Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J. Virol. 2012, 86, 10207-10210. [CrossRef] [PubMed]
45. Noyce, R.S., Delpeut, S., Richardson, C.D. Dog nectin-4 is an epithelial cell receptor for canine distempervirus that facilitates virus entry and syncytia formation. Virology 2013, 436, 210-220. [CrossRef] [PubMed]
46. Wu, N., Veillette, A. Slam family receptors in normal immunity and immune pathologies. Curr. Opin. Immunol. 2016, 38, 45-51. [CrossRef] [PubMed]
47. Leonard, V.H., Hodge, G., Reyes-Del, V.J., McChesney, M.B., Cattaneo, R. Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J. Virol. 2010, 84, 3413-3420. [CrossRef] [PubMed]
48. Leonard, V.H., Sinn, P.L., Hodge, G., Miest, T., Devaux, P., Oezguen, N., Braun, W., McCray, P.B., Jr., McChesney, M.B., Cattaneo, R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Investig. 2008, 118, 2448-2458. [CrossRef] [PubMed]
49. Dorig, R.E., Marcil, A., Chopra, A., Richardson, C.D. The human cd46 molecule is a receptor for measles virus (edmonston strain). Cell 1993, 75, 295-305. [CrossRef]
50. Erlenhofer, C., Duprex, W.P., Rima, B.K., ter Meulen, V., Schneider-Schaulies, J. Analysis of receptor (CD46, CD150) usage by measles virus. J. Gen. Virol. 2002, 83, 1431-1436. [CrossRef] [PubMed]
51. Beineke, A., Puff, C., Seehusen, F., Baumgartner, W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet. Immunol. Immunopathol. 2009, 127, 1-18. [CrossRef] [PubMed]
52. Zurbriggen, A., Graber, H.U., Vandevelde, M. Selective spread and reduced virus release leads to canine distemper virus persistence in the nervous system. Vet. Microbiol. 1995, 44, 281-288. [CrossRef]
53. Wyss-Fluehmann, G., Zurbriggen, A., Vandevelde, M., Plattet, P. Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein. Acta Neuropathol. 2010, 119, 617-630. [CrossRef] [PubMed]
54. Duprex, W.P., McQuaid, S., Hangartner, L., Billeter, M.A., Rima, B.K. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 1999, 73, 9568-9575. [PubMed]
55. Ehrengruber, M.U., Ehler, E., Billeter, M.A., Naim, H.Y. Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J. Virol. 2002, 76, 5720-5728. [CrossRef] [PubMed]
56. Lawrence, D.M., Patterson, C.E., Gales, T.L., D’Orazio, J.L., Vaughn, M.M., Rall, G.F. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J. Virol. 2000, 74, 1908-1918. [CrossRef] [PubMed]
57. Makhortova, N.R., Askovich, P., Patterson, C.E., Gechman, L.A., Gerard, N.P., Rall, G.F. Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 2007, 362, 235-244. [CrossRef] [PubMed]
58. Singh, B.K., Hornick, A.L., Krishnamurthy, S., Locke, A.C., Mendoza, C.A., Mateo, M., Miller-Hunt, C.L., Cattaneo, R., Sinn, P.L. The nectin-4/afadin protein complex and intercellular membrane pores contribute to rapid spread of measles virus in primary human airway epithelia. J. Virol. 2015, 89, 7089-7096. [CrossRef] [PubMed]
59. Alves, L., Khosravi, M., Avila, M., Ader-Ebert, N., Bringolf, F., Zurbriggen, A., Vandevelde, M., Plattet, P. Slam- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes. J. Virol. 2015, 89, 5724-5733. [CrossRef] [PubMed]
60. Klenk, H.D., Garten, W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 1994, 2, 39-43. [CrossRef]
61. Plemper, R.K., Hammond, A.L., Cattaneo, R. Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J. Biol. Chem. 2001, 276, 44239-44246. [CrossRef] [PubMed]
62. Brindley, M.A., Chaudhury, S., Plemper, R.K. Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion. J. Virol. 2015, 89, 1230-1241. [CrossRef] [PubMed]
63. Lescar, J., Roussel, A., Wien, M.W., Navaza, J., Fuller, S.D., Wengler, G., Wengler, G., Rey, F.A. The fusion glycoprotein shell of semliki forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001, 105, 137-148. [CrossRef]
64. White, J.M., Delos, S.E., Brecher, M., Schornberg, K. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008, 43, 189-219. [CrossRef] [PubMed]
65. Baker, K.A., Dutch, R.E., Lamb, R.A., Jardetzky, T.S. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 1999, 3, 309-319. [CrossRef]
66. Plemper, R.K., Compans, R.W. Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J. Virol. 2003, 77, 4181-4190. [CrossRef] [PubMed]
67. Dutch, R.E., Jardetzky, T.S., Lamb, R.A. Virus membrane fusion proteins: Biological machines that undergo a metamorphosis. Biosci. Rep. 2000, 20, 597-612. [CrossRef] [PubMed]
68. Singh, M., Berger, B., Kim, P.S. LearnCoil-VMF: Computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins. J. Mol. Biol. 1999, 290, 1031-1041. [CrossRef] [PubMed]
69. Hughson, F.M. Enveloped viruses: A common mode of membrane fusion? Curr. Biol. CB 1997, 7, R565-R569. [CrossRef]
70. Moll, M., Klenk, H.D., Maisner, A. Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. J. Virol. 2002, 76, 7174-7186. [CrossRef] [PubMed]
71. Paterson, R.G., Russell, C.J., Lamb, R.A. Fusion protein of the paramyxovirus SV5: Destabilizing and stabilizing mutants of fusion activation. Virology 2000, 270, 17-30. [CrossRef] [PubMed]
72. Waning, D.L., Russell, C.J., Jardetzky, T.S., Lamb, R.A. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc. Natl. Acad. Sci. USA 2004, 101, 9217-9222. [CrossRef] [PubMed]
73. Aguilar, H.C., Matreyek, K.A., Choi, D.Y., Filone, C.M., Young, S., Lee, B. Polybasic kkr motif in the cytoplasmic tail of nipah virus fusion protein modulates membrane fusion by inside-out signaling. J. Virol. 2007, 81, 4520-4532. [CrossRef] [PubMed]
74. Runkler, N., Dietzel, E., Moll, M., Klenk, H.D., Maisner, A. Glycoprotein targeting signals influence the distribution of measles virus envelope proteins and virus spread in lymphocytes. J. Gen. Virol. 2008, 89, 687-696. [CrossRef] [PubMed]
75. Runkler, N., Dietzel, E., Carsillo, M., Niewiesk, S., Maisner, A. Sorting signals in the measles virus wild-type glycoproteins differently influence virus spread in polarized epithelia and lymphocytes. J. Gen. Virol. 2009, 90, 2474-2482. [CrossRef] [PubMed]
76. Smith, E.C., Culler, M.R., Hellman, L.M., Fried, M.G., Creamer, T.P., Dutch, R.E. Beyond anchoring: The expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J. Virol. 2012, 86, 3003-3013. [CrossRef] [PubMed]
77. Muhlebach, M.D., Leonard, V.H., Cattaneo, R. The measles virus fusion protein transmembrane region modulates availability of an active glycoprotein complex and fusion efficiency. J. Virol. 2008, 82, 11437-11445. [CrossRef] [PubMed]
78. Chen, L., Colman, P.M., Cosgrove, L.J., Lawrence, M.C., Lawrence, L.J., Tulloch, P.A., Gorman, J.J. Cloning, expression, and crystallization of the fusion protein of newcastle disease virus. Virology 2001, 290, 290-299. [CrossRef] [PubMed]
79. Yin, H.S., Paterson, R.G., Wen, X., Lamb, R.A., Jardetzky, T.S. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc. Natl. Acad. Sci. USA 2005, 102, 9288-9293. [CrossRef] [PubMed]
80. Chen, L., Gorman, J.J., McKimm-Breschkin, J., Lawrence, L.J., Tulloch, P.A., Smith, B.J., Colman, P.M., Lawrence, M.C. The structure of the fusion glycoprotein of newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure 2001, 9, 255-266. [CrossRef]
81. Wong, J.J., Paterson, R.G., Lamb, R.A., Jardetzky, T.S. Structure and stabilization of the hendra virus f glycoprotein in its prefusion form. Proc. Natl. Acad. Sci. USA 2016, 113, 1056-1061. [CrossRef] [PubMed]
82. Xu, K., Chan, Y.P., Bradel-Tretheway, B., Akyol-Ataman, Z., Zhu, Y., Dutta, S., Yan, L., Feng, Y.; Wang, L.F., Skiniotis, G., et al. Crystal structure of the pre-fusion nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly. PLoS Pathog. 2015, 11, e1005322. [CrossRef] [PubMed]
83. McLellan, J.S., Yang, Y., Graham, B.S., Kwong, P.D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 2011, 85, 7788-7796. [CrossRef] [PubMed]
84. McLellan, J.S., Chen, M., Leung, S., Graepel, K.W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. Structure of rsv fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 2013, 340, 1113-1117. [CrossRef] [PubMed]
85. Welch, B.D., Liu, Y., Kors, C.A., Leser, G.P., Jardetzky, T.S., Lamb, R.A. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc. Natl. Acad. Sci. USA 2012, 109, 16672-16677. [CrossRef] [PubMed]
86. Yin, H.S., Wen, X., Paterson, R.G., Lamb, R.A., Jardetzky, T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006, 439, 38-44. [CrossRef] [PubMed]
87. Russell, C.J., Jardetzky, T.S., Lamb, R.A. Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion. EMBO J. 2001, 20, 4024-4034. [CrossRef] [PubMed]
88. Chernomordik, L.V., Kozlov, M.M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 2008, 15, 675-683. [CrossRef] [PubMed]
89. Harrison, S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008, 15, 690-698. [CrossRef] [PubMed]
90. Kozlov, M.M., McMahon, H.T., Chernomordik, L.V. Protein-driven membrane stresses in fusion and fission. Trends Biochem. Sci. 2010, 35, 699-706. [CrossRef] [PubMed]
91. Brindley, M.A., Plattet, P., Plemper, R.K. Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain. Proc. Natl. Acad. Sci. USA 2014, 111, E3795-E3804. [CrossRef] [PubMed]
92. Villar, E., Barroso, I.M. Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview. Glycoconj. J. 2006, 23, 5-17. [CrossRef] [PubMed]
93. Lamb, R.A., Jardetzky, T.S. Structural basis of viral invasion: Lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 2007, 17, 427-436. [CrossRef] [PubMed]
94. Plemper, R.K., Hammond, A.L., Cattaneo, R. Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J. Virol. 2000, 74, 6485-6493. [CrossRef] [PubMed]
95. Yuan, P., Thompson, T.B.; Wurzburg, B.A., Paterson, R.G., Lamb, R.A., Jardetzky, T.S. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 2005, 13, 803-815. [CrossRef] [PubMed]
96. Lawrence, M.C., Borg, N.A., Streltsov, V.A., Pilling, P.A., Epa, V.C., Varghese, J.N., Kimm-Breschkin, J.L., Colman, P.M. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 2004, 335, 1343-1357. [CrossRef] [PubMed]
97. Zaitsev, V., von, I.M., Groves, D., Kiefel, M., Takimoto, T., Portner, A., Taylor, G. Second sialic acid binding site in newcastle disease virus hemagglutinin-neuraminidase: Implications for fusion. J. Virol. 2004, 78, 3733-3741. [CrossRef] [PubMed]
98. Xu, K., Rajashankar, K.R., Chan, Y.P., Himanen, J.P., Broder, C.C., Nikolov, D.B. Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc. Natl. Acad. Sci. USA 2008, 105, 9953-9958. [CrossRef] [PubMed]
99. Bowden, T.A., Crispin, M., Harvey, D.J., Aricescu, A.R., Grimes, J.M., Jones, E.Y., Stuart, D.I. Crystal structure and carbohydrate analysis of nipah virus attachment glycoprotein: A template for antiviral and vaccine design. J. Virol. 2008, 82, 11628-11636. [CrossRef] [PubMed]
100. Santiago, C., Celma, M.L., Stehle, T., Casasnovas, J.M. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat. Struct. Mol. Biol. 2010, 17, 124-129. [CrossRef] [PubMed]
101. Colf, L.A., Juo, Z.S., Garcia, K.C. Structure of the measles virus hemagglutinin. Nat. Struct. Mol. Biol. 2007, 14, 1227-1228. [CrossRef] [PubMed]
102. Hashiguchi, T., Kajikawa, M., Maita, N., Takeda, M., Kuroki, K., Sasaki, K., Kohda, D., Yanagi, Y., Maenaka, K. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc. Natl. Acad. Sci. USA 2007, 104, 19535-19540. [CrossRef] [PubMed]
103. Hashiguchi, T., Ose, T., Kubota, M., Maita, N., Kamishikiryo, J., Maenaka, K., Yanagi, Y. Structure of the measles virus hemagglutinin bound to its cellular receptor slam. Nat. Struct. Mol. Biol. 2011, 18, 135-141. [CrossRef] [PubMed]
104. Zhang, X., Lu, G., Qi, J., Li, Y., He, Y., Xu, X., Shi, J., Zhang, C.W., Yan, J., Gao, G.F. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat. Struct. Mol. Biol. 2013, 20, 67-72. [CrossRef] [PubMed]
105. Yuan, P., Swanson, K.A., Leser, G.P., Paterson, R.G., Lamb, R.A., Jardetzky, T.S. Structure of the newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc. Natl. Acad. Sci. USA 2011, 108, 14920-14925. [CrossRef] [PubMed]
106. Yuan, P., Paterson, R.G., Leser, G.P., Lamb, R.A., Jardetzky, T.S. Structure of the ulster strain newcastle disease virus hemagglutinin-neuraminidase reveals auto-inhibitory interactions associated with low virulence. PLoS Pathog. 2012, 8, e1002855. [CrossRef] [PubMed]
107. Welch, B.D., Yuan, P., Bose, S., Kors, C.A., Lamb, R.A., Jardetzky, T.S. Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain. PLoS Pathog. 2013, 9, e1003534. [CrossRef] [PubMed]
108. Ader, N., Brindley, M.A., Avila, M., Origgi, F.C., Langedijk, J.P., Orvell, C., Vandevelde, M., Zurbriggen, A., Plemper, R.K., Plattet, P. Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger f protein refolding for membrane fusion. J. Biol. Chem. 2012, 287, 16324-16334. [CrossRef] [PubMed]
109. Navaratnarajah, C.K., Negi, S., Braun, W., Cattaneo, R. Membrane fusion triggering: Three modules with different structure and function in the upper half of the measles virus attachment protein stalk. J. Biol. Chem. 2012, 287, 38543-38551. [CrossRef] [PubMed]
110. Brindley, M.A., Takeda, M., Plattet, P., Plemper, R.K. Triggering the measles virus membrane fusion machinery. Proc. Natl. Acad. Sci. USA 2012, 109, E3018-E3027. [CrossRef] [PubMed]
111. Heminway, B.R., Yu, Y., Galinski, M.S. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res. 1994, 31, 1-16. [CrossRef]
112. Hu, X.L., Ray, R., Compans, R.W. Functional interactions between the fusion protein and hemagglutininneuraminidase of human parainfluenza viruses. J. Virol. 1992, 66, 1528-1534. [PubMed]
113. Morrison, T., McQuain, C., McGinnes, L. Complementation between avirulent newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: Requirements for membrane fusion. J. Virol. 1991, 65, 813-822. [PubMed]
114. Lee, J.K., Prussia, A., Paal, T., White, L.K., Snyder, J.P., Plemper, R.K. Functional interaction between paramyxovirus fusion and attachment proteins. J. Biol. Chem. 2008, 283, 16561-16572. [CrossRef] [PubMed]
115. Deng, R., Wang, Z., Mirza, A.M., Iorio, R.M. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 1995, 209, 457-469. [CrossRef] [PubMed]
116. Deng, R., Mirza, A.M., Mahon, P.J., Iorio, R.M. Functional chimeric HN glycoproteins derived from newcastle disease virus and human parainfluenza virus-3. Arch. Virol. Suppl. 1997, 13, 115-130. [PubMed]
117. Tanabayashi, K., Compans, R.W. Functional interaction of paramyxovirus glycoproteins: Identification of a domain in sendai virus hn which promotes cell fusion. J. Virol. 1996, 70, 6112-6118. [PubMed]
118. Wang, Z., Mirza, A.M., Li, J., Mahon, P.J., Iorio, R.M. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion. Virus Res. 2004, 99, 177-185. [CrossRef] [PubMed]
119. Tsurudome, M., Kawano, M., Yuasa, T., Tabata, N., Nishio, M., Komada, H., Ito, Y. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 1995, 213, 190-203. [CrossRef] [PubMed]
120. Pte-Sengupta, S., Navaratnarajah, C.K., Cattaneo, R. Hydrophobic and charged residues in the central segment of the measles virus hemagglutinin stalk mediate transmission of the fusion-triggering signal. J. Virol. 2013, 87, 10401-10404. [CrossRef] [PubMed]
121. Navaratnarajah, C.K., Kumar, S., Generous, A., pte-Sengupta, S., Mateo, M., Cattaneo, R. The mea slesvirus hemagglutinin stalk: Structures and functions of the central fusion activation and membrane-proximal segments. J. Virol. 2014, 88, 6158-6167. [CrossRef] [PubMed]
122. Bose, S., Zokarkar, A.; Welch, B.D., Leser, G.P., Jardetzky, T.S., Lamb, R.A. Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc. Natl. Acad. Sci. USA 2012, 109, E2625-E2634. [CrossRef] [PubMed]
123. Bose, S., Song, A.S., Jardetzky, T.S., Lamb, R.A. Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells. J. Virol. 2014, 88, 3925-3941. [CrossRef] [PubMed]
124. Brindley, M.A., Suter, R., Schestak, I., Kiss, G.; Wright, E.R., Plemper, R.K. A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion. J. Virol. 2013, 87, 11693-11703. [CrossRef] [PubMed]
125. Liu, Q., Stone, J.A., Bradel-Tretheway, B., Dabundo, J., avides Montano, J.A., Santos-Montanez, J., Biering, S.B., Nicola, A.V., Iorio, R.M., Lu, X., et al. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced nipah virus fusion and cell entry. PLoS Pathog. 2013, 9, e1003770. [CrossRef] [PubMed]
126. Ader-Ebert, N., Khosravi, M., Herren, M., Avila, M., Alves, L., Bringolf, F., Orvell, C., Langedijk, J.P., Zurbriggen, A., Plemper, R.K., et al. Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process. PLoS Pathog. 2015, 11, e1004880. [CrossRef] [PubMed]
127. Navaratnarajah, C.K., Rosemarie, Q., Cattaneo, R. A structurally unresolved head segment of defined length favors proper measles virus hemagglutinin tetramerization and efficient membrane fusion triggering. J. Virol. 2015, 90, 68-75. [CrossRef] [PubMed]
128. Bose, S., Jardetzky, T.S., Lamb, R.A. Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry. Virology 2015, 479, 518-531. [CrossRef] [PubMed]
129. Aguilar, H.C., Matreyek, K.A., Filone, C.M., Hashimi, S.T., Levroney, E.L., Negrete, O.A., Bertolotti-Ciarlet, A., Choi, D.Y., McHardy, I., Fulcher, J.A., et al. N-glycans on nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 2006, 80, 4878-4889. [CrossRef] [PubMed]
130. Aguilar, H.C., Ataman, Z.A., Aspericueta, V., Fang, A.Q., Stroud, M., Negrete, O.A., Kammerer, R.A., Lee, B. A novel receptor-induced activation site in the nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J. Biol. Chem. 2009, 284, 1628-1635. [CrossRef] [PubMed]
131. Apte-Sengupta, S., Negi, S., Leonard, V.H., Oezguen, N., Navaratnarajah, C.K., Braun, W., Cattaneo, R. Base of the measles virus fusion trimer head receives the signal that triggers membrane fusion. J. Biol. Chem. 2012, 287, 33026-33035. [CrossRef] [PubMed]
132. Bose, S., Heath, C.M., Shah, P.A., Alayyoubi, M., Jardetzky, T.S., Lamb, R.A. Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability. J. Virol. 2013, 87, 13520-13531. [CrossRef] [PubMed]
133. Avila, M., Khosravi, M., Alves, L., Ader-Ebert, N., Bringolf, F., Zurbriggen, A., Plemper, R.K., Plattet, P. Canine distemper virus envelope protein interactions modulated by hydrophobic residues in the fusion protein globular head. J. Virol. 2015, 89, 1445-1451. [CrossRef] [PubMed]
134. Paal, T., Brindley, M.A., St, C.C., Prussia, A., Gaus, D., Krumm, S.A., Snyder, J.P., Plemper, R.K. Probing the spatial organization of measles virus fusion complexes. J. Virol. 2009, 83, 10480-10493. [CrossRef] [PubMed]
135. Connolly, S.A., Leser, G.P., Jardetzky, T.S., Lamb, R.A. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: Implications for the mechanism of fusion triggering. J. Virol. 2009, 83, 10857-10868. [CrossRef] [PubMed]
136. Paterson, R.G., Johnson, M.L., Lamb, R.A. Paramyxovirus fusion (F) protein and hemagglutininneuraminidase (HN) protein interactions: Intracellular retention of f and hn does not affect transport of the homotypic hn or f protein. Virology 1997, 237, 1-9. [CrossRef] [PubMed]
137. Ader, N., Brindley, M., Avila, M., Orvell, C., Horvat, B., Hiltensperger, G., Schneider-Schaulies, J., Vandevelde, M., Zurbriggen, A., Plemper, R.K., et al. Mechanism for active membrane fusion triggering by morbillivirus attachment protein. J. Virol. 2013, 87, 314-326. [CrossRef] [PubMed]
138. Chan, Y.P., Lu, M., Dutta, S., Yan, L., Barr, J., Flora, M., Feng, Y.R., Xu, K., Nikolov, D.B., Wang, L.F., et al. Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. J. Virol. 2012, 86, 11457-11471. [CrossRef] [PubMed]
139. Talekar, A., Moscona, A., Porotto, M. Measles virus fusion machinery activated by sialic acid binding globular domain. J. Virol. 2013, 87, 13619-13627. [CrossRef] [PubMed]
140. Khosravi, M., Bringolf, F., Rothlisberger, S., Bieringer, M., Schneider-Schaulies, J., Zurbriggen, A., Origgi, F., Plattet, P. Canine distemper virus fusion activation: Critical role of residue E123 of CD150/SLAM. J. Virol. 2015, 90, 1622-1637. [CrossRef] [PubMed]
141. Plattet, P., Langedijk, J.P., Zipperle, L., Vandevelde, M., Orvell, C., Zurbriggen, A. Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity. Biochemistry 2009, 48, 9112-9121. [CrossRef] [PubMed]
142. Porotto, M., Palmer, S.G., Palermo, L.M., Moscona, A. Mechanism of fusion triggering by human parainfluenza virus type III: Communication between viral glycoproteins during entry. J. Biol. Chem. 2012, 287, 778-793. [CrossRef] [PubMed]
143. Gui, L., Jurgens, E.M., Ebner, J.L., Porotto, M., Moscona, A., Lee, K.K. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: Association of receptor binding and fusion proteins before receptor engagement. mBio 2015, 6, e02393-14. [CrossRef] [PubMed]
144. Xu, R., Palmer, S.G., Porotto, M., Palermo, L.M., Niewiesk, S., Wilson, I.A., Moscona, A. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. MBio 2013, 4, e00803-e00813. [CrossRef] [PubMed]
145. Crennell, S., Takimoto, T., Portner, A., Taylor, G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 2000, 7, 1068-1074. [PubMed]
146. Lamb, R.A. Paramyxovirus fusion: A hypothesis for changes. Virology 1993, 197, 1-11. [CrossRef] [PubMed]
147. Sergel, T., McGinnes, L.W., Peeples, M.E., Morrison, T.G. The attachment function of the newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 1993, 193, 717-726. [CrossRef] [PubMed]
148. Avila, M., Alves, L., Khosravi, M., der-Ebert, N., Origgi, F., Schneider-Schaulies, J., Zurbriggen, A., Plemper, R.K., Plattet, P. Molecular determinants defining the triggering range of prefusion f complexes of canine distemper virus. J. Virol. 2014, 88, 2951-2966. [CrossRef] [PubMed]
149. Shirogane, Y., Watanabe, S., Yanagi, Y. Cooperation between different RNA virus genomes produces a new phenotype. Nat. Commun. 2012, 3. [CrossRef] [PubMed]
150. Summers, B.A., Greisen, H.A., Appel, M.J. Early events in canine distemper demyelinating encephalomyelitis. Acta Neuropathol. 1979, 46, 1-10. [CrossRef] [PubMed]
151. Summers, B.A., Greisen, H.A., Appel, M.J. Canine distemper encephalomyelitis: Variation with virus strain. J. Comp. Pathol. 1984, 94, 65-75. [CrossRef]
152. Summers, B.A., Whitaker, J.N., Appel, M.J. Demyelinating canine distemper encephalomyelitis: Measurement of myelin basic protein in cerebrospinal fluid. J. Neuroimmunol. 1987, 14, 227-233. [CrossRef]
153. Wild, C.T., Shugars, D.C., Greenwell, T.K., McDanal, C.B., Matthews, T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 1994, 91, 9770-9774. [CrossRef] [PubMed]
154. Jiang, S., Lin, K., Strick, N., Neurath, A.R. HIV-1 inhibition by a peptide. Nature 1993, 365, 113. [CrossRef] [PubMed]
155. Bossart, K.N., Wang, L.F., Eaton, B.T., Broder, C.C. Functional expression and membrane fusion tropism of the envelope glycoproteins of hendra virus. Virology 2001, 290, 121-135. [CrossRef] [PubMed]
156. Bossart, K.N., Wang, L.F., Flora, M.N., Chua, K.B., Lam, S.K., Eaton, B.T., Broder, C.C. Membrane fusion tropism and heterotypic functional activities of the nipah virus and hendra virus envelope glycoproteins. J. Virol. 2002, 76, 11186-11198. [CrossRef] [PubMed]
157. Lambert, D.M., Barney, S., Lambert, A.L., Guthrie, K., Medinas, R., Davis, D.E., Bucy, T., Erickson, J., Merutka, G., Petteway, S.R., Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 1996, 93, 2186-2191. [CrossRef] [PubMed]
158. Joshi, S.B., Dutch, R.E., Lamb, R.A. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 1998, 248, 20-34. [CrossRef] [PubMed]
159. Young, J.K., Hicks, R.P., Wright, G.E., Morrison, T.G. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, nmr, and molecular modeling. Virology 1997, 238, 291-304. [CrossRef] [PubMed]
160. Bossart, K.N., Mungall, B.A., Crameri, G., Wang, L.F., Eaton, B.T., Broder, C.C. Inhibition of henipavirus fusion and infection by heptad-derived peptides of the nipah virus fusion glycoprotein. Virol. J. 2005, 2. [CrossRef] [PubMed]
161. Porotto, M., Rockx, B., Yokoyama, C.C., Talekar, A., Devito, I., Palermo, L.M., Liu, J., Cortese, R., Lu, M., Feldmann, H., et al. Inhibition of nipah virus infection in vivo: Targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog. 2010, 6, e1001168. [CrossRef] [PubMed]
162. Lee, K.K., Pessi, A., Gui, L., Santoprete, A., Talekar, A., Moscona, A., Porotto, M. Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus. J. Biol. Chem. 2011, 286, 42141-42149. [CrossRef] [PubMed]
163. Ingallinella, P., Bianchi, E., Ladwa, N.A.; Wang, Y.J., Hrin, R., Veneziano, M., Bonelli, F., Ketas, T.J., Moore, J.P., Miller, M.D., et al. Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency. Proc. Natl. Acad. Sci. USA 2009, 106, 5801-5806. [CrossRef] [PubMed]
164. Malvoisin, E., Wild, F. Contribution of measles virus fusion protein in protective immunity: Anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 1990, 64, 5160-5162. [PubMed]
165. Sheshberadaran, H., Chen, S.N., Norrby, E. Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology 1983, 128, 341-353. [CrossRef]
166. Young, M.K., Nimmo, G.R., Cripps, A.W., Jones, M.A. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst. Rev. 2014, 4. [CrossRef]
167. Hampp, C., Kauf, T.L., Saidi, A.S., Winterstein, A.G. Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications. Arch. Pediatr. Adolesc. Med. 2011, 165, 498-505. [CrossRef] [PubMed]
168. Mahadevia, P.J., Masaquel, A.S., Polak, M.J., Weiner, L.B. Cost utility of palivizumab prophylaxis among pre-term infants in the united states: A national policy perspective. J. Med. Econ. 2012, 15, 987-996. [CrossRef] [PubMed]
169. Plemper, R.K., Erlandson, K.J., Lakdawala, A.S., Sun, A., Prussia, A., Boonsombat, J., ki-Sener, E., Yalcin, I., Yildiz, I., Temiz-Arpaci, O., et al. A target site for template-based design of measles virus entry inhibitors. Proc. Natl. Acad. Sci. USA 2004, 101, 5628-5633. [CrossRef] [PubMed]
170. Plemper, R.K., Doyle, J., Sun, A., Prussia, A., Cheng, L.T., Rota, P.A., Liotta, D.C., Snyder, J.P., Compans, R.W. Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob. Agents Chemother. 2005, 49, 3755-3761. [CrossRef] [PubMed]
171. Sun, A., Prussia, A., Zhan, W., Murray, E.E., Doyle, J., Cheng, L.T., Yoon, J.J., Radchenko, E.V., Palyulin, V.A., Compans, R.W., et al. Nonpeptide inhibitors of measles virus entry. J. Med. Chem. 2006, 49, 5080-5092. [CrossRef] [PubMed]
172. Singethan, K., Hiltensperger, G., Kendl, S., Wohlfahrt, J., Plattet, P., Holzgrabe, U., Schneider-Schaulies, J. N-(3-cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicity. J. Gen. Virol. 2010, 91, 2762-2772. [CrossRef] [PubMed]
173. Sun, A., Yoon, J.J., Yin, Y., Prussia, A., Yang, Y., Min, J., Plemper, R.K., Snyder, J.P. Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex. J. Med. Chem. 2008, 51, 3731-3741. [CrossRef] [PubMed]
174. Domingo, E., Holland, J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997, 51, 151-178. [CrossRef] [PubMed]
175. Domingo, E., Sheldon, J., Perales, C. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 2012, 76, 159-216. [CrossRef] [PubMed]
176. Doyle, J., Prussia, A., White, L.K., Sun, A., Liotta, D.C., Snyder, J.P., Compans, R.W., Plemper, R.K. Two domains that control prefusion stability and transport competence of the measles virus fusion protein. J. Virol. 2006, 80, 1524-1536. [CrossRef] [PubMed]
177. Prussia, A.J., Plemper, R.K., Snyder, J.P. Measles virus entry inhibitors: A structural proposal for mechanism of action and the development of resistance. Biochemistry 2008, 47, 13573-13583. [CrossRef] [PubMed]
178. Yan, D., Lee, S., Thakkar, V.D., Luo, M., Moore, M.L., Plemper, R.K. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors. Proc. Natl. Acad. Sci. USA 2014, 111, E3441-E3449. [CrossRef] [PubMed]
179. Cianci, C., Yu, K.L., Combrink, K., Sin, N., Pearce, B.; Wang, A., Civiello, R., Voss, S., Luo, G., Kadow, K., et al. Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob. Agents Chemother. 2004, 48, 413-422. [CrossRef] [PubMed]
180. Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Sommen, C., Lacrampe, J., Janssens, F., Wyde, P.R. Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antivir. Res. 2003, 60, 209-219. [CrossRef] [PubMed]
181. Bonfanti, J.F., Meyer, C., Doublet, F., Fortin, J., Muller, P., Queguiner, L., Gevers, T., Janssens, P., Szel, H., Willebrords, R., et al. Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121). J. Med. Chem. 2008, 51, 875-896. [CrossRef] [PubMed]
182. Battles, M.B., Langedijk, J.P., Furmanova-Hollenstein, P., Chaiwatpongsakorn, S., Costello, H.M., Kw anten, L., Vranckx, L., Vink, P., Jaensch, S., Jonckers, T.H., et al. Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nat. Chem. Biol. 2016, 12, 87-93. [CrossRef] [PubMed]
183. Poor, T.A., Jones, L.M., Sood, A., Leser, G.P., Plasencia, M.D., Rempel, D.L., Jardetzky, T.S., Woods, R.J., Gross, M.L., Lamb, R.A. Probing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting. Proc. Natl. Acad.Sci. USA 2014, 111, E2596-E2605. [CrossRef] [PubMed]
184. Gibbs, F.A., Gibbs, E.L., Carpenter, P.R., Spies, H.W. Electroencephalographic abnormality in “uncomplicated” childhood diseases. J. Am. Med. Assoc. 1959, 171, 1050-1055. [CrossRef] [PubMed]
185. Pampiglione, G. Prodromal phase of measles: Some neurophysiological studies. Br. Med. J. 1964, 2, 1296-1300. [CrossRef] [PubMed]
186. Budka, H., Urbanits, S., Liberski, P.P., Eichinger, S., Popow-Kraupp, T. Subacute measles virus encephalitis: A new and fatal opportunistic infection in a patient with aids. Neurology 1996, 46, 586-587. [CrossRef] [PubMed]
187. Mustafa, M.M., Weitman, S.D., Winick, N.J., Bellini, W.J., Timmons, C.F., Siegel, J.D. Subacute measles encephalitis in the young immunocompromised host: Report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin. Infect. Dis. 1993, 16, 654-660. [CrossRef] [PubMed]
188. Cattaneo, R., Schmid, A., Rebmann, G., Baczko, K., ter, M.V., Bellini, W.J., Rozenblatt, S., Billeter, M.A. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: Interrupted matrix protein reading frame and transcription alteration. Virology 1986, 154, 97-107. [CrossRef]
189. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter, M.V., Billeter, M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55, 255-265. [CrossRef]
190. Wong, T.C., Ayata, M., Ueda, S., Hirano, A. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 1991, 65, 2191-2199. [PubMed]
191. Baczko, K., Lampe, J., Liebert, U.G., Brinckmann, U., ter Meulen, V., Pardowitz, I., Budka, H., Cosby, S.L., Isserte, S., Rima, B.K. Clonal expansion of hypermutated measles virus in a sspe brain. Virology 1993, 197, 188-195. [CrossRef] [PubMed]
192. Schmid, A., Spielhofer, P., Cattaneo, R., Baczko, K., ter Meulen, V., Billeter, M.A. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992, 188, 910-915. [CrossRef]
193. Watanabe, S., Shirogane, Y., Suzuki, S.O., Ikegame, S., Koga, R., Yanagi, Y. Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters. J. Virol. 2013, 87, 2648-2659. [CrossRef] [PubMed]
194. Watanabe, S., Ohno, S., Shirogane, Y., Suzuki, S.O., Koga, R., Yanagi, Y. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. J. Virol. 2015, 89, 2710-2717. [CrossRef] [PubMed]
195. Hardie, D.R., Albertyn, C., Heckmann, J.M., Smuts, H.E. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Virol. J. 2013, 10. [CrossRef] [PubMed]
196. Jurgens, E.M., Mathieu, C., Palermo, L.M., Hardie, D., Horvat, B., Moscona, A., Porotto, M. Measles fusion machinery is dysregulated in neuropathogenic variants. mBio 2015, 6, e02528-14. [CrossRef] [PubMed]